UNH Stock Ownership Activity

UNITEDHEALTH GROUP INC 13F holders

12 value investing gurus have made changes to the UNITEDHEALTH GROUP INC (UNH) position according to the gurus' latest SEC quarterly report(s). UNH has been completely sold out by 1 guru(s), the number of UNH shares has been increased by 2, decreased by 9 super investor(s).

Which gurus or hedge funds are buying UNH now?

According to the latest SEC filing(s) UNITEDHEALTH GROUP INC (UNH) has been bought by 2 gurus: Robert Olstein - Olstein Capital Management (added shares +93.33%) and Ronald Muhlenkamp - Muhlenkamp & Co (added shares +0.73%).

To see more about who is investing in UNITEDHEALTH GROUP INC (UNH), please go to the UNH ownership page.

2017 Q1 (10 results)
Ole Andreas Halvorsen
+61.58%
+1,363,016
+0.99%
2.59%
David Tepper
buy
+300,000
+0.86%
0.86%
Sarah Ketterer
+16.64%
+173,916
+0.44%
3.11%
Rich Handler, Brian Friedman
buy
+2,995
+0.04%
0.00%
Ronald Muhlenkamp
-0.13%
-75
-0.00%
3.14%
Eric H. Schoenstein
-0.14%
-2,620
-0.01%
4.44%
C.T. Fitzpatrick
-1.02%
-6,123
-0.01%
0.84%
Robert Olstein
-21.15%
-11,000
-0.23%
0.86%
Nathaniel Simons
-100.00%
-16,798
-0.09%
0.00%
Ravenel Boykin Curry IV
-4.06%
-266,469
-0.18%
4.22%
Current price: $501.13 200.63% AVG reported price*: $166.69
2016 Q4 (8 results)
Ole Andreas Halvorsen
buy
+2,213,236
+1.61%
1.61%
Sarah Ketterer
+4.03%
+40,501
+0.13%
3.43%
Nathaniel Simons
buy
+16,798
+0.10%
0.00%
Robert Olstein
+6.12%
+3,000
+0.06%
1.07%
Ronald Muhlenkamp
-0.95%
-565
-0.03%
3.16%
Eric H. Schoenstein
-0.15%
-2,885
-0.01%
4.54%
C.T. Fitzpatrick
-35.71%
-331,937
-0.47%
0.85%
Ravenel Boykin Curry IV
-6.68%
-470,143
-0.32%
4.45%
Current price: $501.13 206.61% AVG reported price*: $163.44
2016 Q3 (7 results)
C.T. Fitzpatrick
buy
+929,431
+1.20%
1.20%
Sarah Ketterer
+4.21%
+40,607
+0.12%
2.90%
Robert Olstein
+6.52%
+3,000
+0.06%
0.90%
Ronald Muhlenkamp
-0.93%
-560
-0.03%
3.20%
Eric H. Schoenstein
-0.38%
-7,370
-0.02%
4.06%
Leon Cooperman
-100.00%
-493,800
-2.15%
0.00%
Ravenel Boykin Curry IV
-7.16%
-542,312
-0.33%
4.25%
Current price: $501.13 250.67% AVG reported price*: $142.91
2016 Q2 (6 results)
Ronald Muhlenkamp
-0.43%
-260
-0.01%
3.35%
Leon Cooperman
-1.14%
-5,700
-0.02%
0.00%
Robert Olstein
-16.36%
-9,000
-0.17%
0.88%
Eric H. Schoenstein
-0.94%
-18,457
-0.04%
4.27%
Sarah Ketterer
-12.26%
-134,796
-0.46%
3.32%
Ravenel Boykin Curry IV
-3.02%
-236,131
-0.14%
4.60%
Current price: $501.13 246.53% AVG reported price*: $144.62
2016 Q1 (6 results)
Leon Cooperman
buy
+499,500
+1.71%
1.71%
Eric H. Schoenstein
+4.29%
+80,910
+0.17%
4.04%
Ronald Muhlenkamp
buy
+60,480
+3.21%
3.21%
Robert Olstein
-9.84%
-6,000
-0.10%
0.95%
Sarah Ketterer
-1.66%
-18,511
-0.06%
3.79%
Ravenel Boykin Curry IV
-1.07%
-84,825
-0.05%
4.22%
Current price: $501.13 278.48% AVG reported price*: $132.40
2015 Q4 (4 results)
Eric H. Schoenstein
+38.43%
+523,330
+1.03%
3.72%
Ravenel Boykin Curry IV
+4.08%
+309,704
+0.15%
3.80%
Sarah Ketterer
+8.04%
+83,130
+0.25%
3.34%
Robert Olstein
+5.17%
+3,000
+0.05%
0.93%
Current price: $501.13 305.59% AVG reported price*: $123.56
2015 Q3 (4 results)
Sarah Ketterer
+27.85%
+225,344
+0.65%
2.98%
Eric H. Schoenstein
+0.70%
+9,445
+0.02%
2.78%
Robert Olstein
-12.12%
-8,000
-0.12%
0.84%
Ravenel Boykin Curry IV
-12.90%
-1,123,677
-0.57%
3.86%
Current price: $501.13 308.12% AVG reported price*: $122.79
2015 Q2 (4 results)
Sarah Ketterer
+11.97%
+86,498
+0.31%
2.88%
Robert Olstein
+15.79%
+9,000
+0.11%
0.84%
Eric H. Schoenstein
+0.39%
+5,233
+0.01%
2.64%
Ravenel Boykin Curry IV
-20.08%
-2,189,887
-1.05%
4.18%
Current price: $501.13 294.17% AVG reported price*: $127.13
49 of 433

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.